Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07807202 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up

StatusActive, Not Recruiting
PhaseNot applicable
Started2026-04-08
View on ClinicalTrials.gov ↗
The goal of this trial is to learn if a community health worker (CHW) follow-up program can improve HPV vaccination coverage among adolescent girls in Mali and Côte d'Ivoire. The main questions it aims to answer are: Does the CHW follow-up program increase the number of girls who get vaccinated against HPV? Does the CHW follow-up program help girls get vaccinated sooner? Researchers will compare girls who receive proactive CHW home visits and digital follow-up reminders to girls who receive standard community outreach, to see if the CHW follow-up program works to increase HPV vaccination. Participants will: Be visited at home by a community health worker, who will check their HPV vaccination status Receive an invitation to get vaccinated, and reminders and follow-up visits if not yet vaccinated (intervention group only, until crossover) Have their vaccination status recorded through routine community health records, with no additional tests, surveys, or clinic visits required After an initial assessment period, girls in the standard-outreach group will also begin receiving the CHW follow-up program.

Amendment history 1 change detected by DataLookout

2026-09-16
notable
Sponsor changed: Muso Health → Arsène Brunelle Sandie
WasMuso Health
NowArsène Brunelle Sandie
Trial Details
NCT Number NCT07807202
Lead Sponsor Arsène Brunelle Sandie
Collaborators: Programme Élargi de Vaccination (Côte d'Ivoire), Centre National d'Immunisation (Mali)
Conditions Papillomavirus Infections, Uterine Cervical Neoplasms
Enrollment 17,188 participants
Start Date 2026-04-08
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-15